About
Mike Grey is a veteran life-sciences executive and venture partner at Pappas Capital, where he has served since January 2010. He has founded or led multiple biotech companies including Mirum, Lumena, Reneo, Amplyx, SGX, and Trega, and has held chair or board roles across public and private biopharma companies. His profile is strongest in biotech company building, governance, and venture-backed drug development rather than documented personal capital deployment.
Areas of interest
biotechlife sciencesrare diseaseorphan drugsliver diseaseendocrinologyoncologyprecision medicineprotein degradationoncolytic virusesventure capital